Daffoworth Pharmaceutical Private Limited, a active private limited company, was established on 09 September 2014 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24232TG2014PTC095611. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 8 professional, Its leadership includes Jha Anita (Director), Dharmendra Kumar Jha (Managing Director). Past directors included Balvinder Kaur, Vineet Choudhary Kumar. It holds ₹1.21 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 1-62/K/1/44 Kavuri Hills Phase 1, Hyderabad, Telangana, 500033.
U24232TG2014PTC095611
095611
09 September 2014
₹1.00 Cr
₹1.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Daffoworth Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jha Anita | Director | 09 Sep 2014 | Current |
| Dharmendra Kumar Jha | Managing Director | 09 Sep 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 15 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Daffoworth Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.66% increase. The company also saw a substantial fall in profitability, with a 22.17% decrease in profit. The company's net worth Soared by an impressive increase of 15.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Daffoworth Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹12,089,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2024 | Others | ₹1.00 Cr | Open |
| 22 Mar 2024 | Others | ₹2.09 M | Open |
Explore comprehensive loan charge details -
Daffoworth Pharmaceutical has a workforce of 8 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Daffoworth Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffoworth Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 1.00 Cr registered on 16 May 2024 with Charge ID 100932993 was modified on 13 Jun 2025. was documented.
Progress on Daffoworth Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100932993 was registered on 16 May 2024. was documented.
The activity Daffoworth Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on A charge with Others amounted to Rs. 0.21 Cr with Charge ID 100899703 was registered on 22 Mar 2024. was documented.
Progress on Jha Anita was appointed as a Director was appointed as a Director on 09 Sep 2014 & has been associated with this company since 11 years 3 months . was documented.
The CIN of Daffoworth Pharmaceutical Private Limited is U24232TG2014PTC095611.
Daffoworth Pharmaceutical Private Limited is headquartered at Plot No. 1-62/K/1/44 Kavuri Hills Phase 1, Hyderabad, Telangana, 500033.
Daffoworth Pharmaceutical Private Limited was incorporated on 09 September 2014.
The current directors of Daffoworth Pharmaceutical Private Limited are
The primary industry of Daffoworth Pharmaceutical Private Limited is Hospital And Medical Care.
Daffoworth Pharmaceutical Private Limited is unlisted.
The authorized capital of Daffoworth Pharmaceutical Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Daffoworth Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX